Press release from Companies

Publicerat: 2022-09-06 15:29:08

Eevia Health Plc: Eevia Health Plc receives starting sales orders from new Asian customers

Eevia Health Plc, ("Eevia" or "The Company"), has received two small starting sales orders from South Korea and Taiwan, totaling approx. 24 KEUR for organically certified bilberry extracts.

The South Korean customer is new to Eevia. It is a natural health company based out of Soul selling its consumer products in Asia. The product is a highly concentrated and organically certified bilberry extract with 25% anthocyanins. The start order was for 13 KEUR.

Similarly, Eevia received a small order from a Taiwanese customer for 11 KEUR. This is also a bilberry extract, Eevia’s branded Feno-Myrtillus 25 Organic (25% anthocyanins), which will be used as an ingredient in supplement formulas marketed in the Taiwanese domestic market.


Both orders were prepaid and shipped immediately upon payment.


“Although these are small start orders, which take less than a day to produce, we are happy to do business with Asian customers, which are keenly focused on high quality. We can do much more in Asia, and that may be one of our targets for 2023” says Anna-Maija Vanhatalo, Customer Service Manager, Eevia Health.


For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                         

Email: stein.ulve@eeviahealth.com                    

Telephone: +358 400 22 5967                              





Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth. 


Läs mer hos Cision
Läs mer om Eevia Health Plc